During the past decade, Upstate Infectious Diseases Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upstate Infectious Diseases Associates" #1 collaborator was "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Upstate Infectious Diseases Associates" are "HIV-1 Infection" (4 trials), "HIV Infections" (3 trials), "Aspergillosis" (2 trials), "HIV" (2 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Upstate Infectious Diseases Associates" in a lesser frequency.

Most popular intervention types in "Upstate Infectious Diseases Associates" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (2 trials), "EFV/FTC/TDF" (2 trials), "FTC/RPV/TAF" (2 trials), "FTC/RPV/TAF Placebo" (2 trials) and "FTC/RPV/TDF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Infectious Diseases Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Upstate Infectious Diseases Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Upstate Infectious Diseases Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Infectious Diseases Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".